Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 1
2(66.7%)
Phase 4
1(33.3%)
3Total
Phase 1(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07488897Phase 1Recruiting

RIG 101 Trial in Healthy Adults and Adults With Asthma

Role: collaborator

NCT03930264Phase 1Completed

Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®)

Role: collaborator

NCT04256044Completed

Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020

Role: collaborator

NCT03842904Phase 4Completed

A Study Comparing the Effects of Trimbow to Fostair in COPD

Role: lead

All 4 trials loaded